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Objective: This study presents technical aspects and initial results with iliac bifurcated devices (IBDs).
Methods: Since 2006, 47 IBDs were scheduled for 37 patients who were followed up between 2 and 31 months. Iliac
aneurysms were unilateral in 27 patients and bilateral in 10. Two patients with bilateral common iliac artery aneurysms
(CIAAs) did not have a simultaneous aortic aneurysm. Two patients underwent combined thoracoabdominal aneurysm
treatment with branched stent grafts, and one underwent combined juxtarenal aneurysm repair with a fenestrated device.
The helical iliac side branch device was used in 11 CIAA (23.4%), and the Zenith bifurcated iliac side branch device was
used in the remaining 36 (76.6%).
Results: The technical success rate was 97.3% within the 47 intended-to-treat CIAAs (failure to introduce the delivery system
in one case, converted to femorofemoral bypass).During follow-up, five (10.6%) hypogastric branchocclusions occurred in five
patients. Two patients with bilateral repair had unilateral internal iliac artery side branch occlusions without ischemic
symptoms. In contrast, of the three patients with unilateral side branch occlusion and simultaneous contralateral internal iliac
artery occlusion (2 chronic and 1 coil embolization), persistent buttock claudication and sexual dysfunction developed in one.
The secondary patency, including one redo case, was 87.3% at 22 months (standard error <10%).
Conclusions: The use of branched stent grafts is a feasible procedure, including for patients with bilateral iliac aneurysmal
disease or concomitant juxtarenal or thoracoabdominal aortic disease. ( J Vasc Surg 2010;51:545-50.)The endovascular aortic repair (EVAR) of an abdomi-
nal aortic aneurysm (AAA) is now a well-established treat-
ment, and its general acceptance has prompted us to a
widespread use of this technique. Its applicability can be
constrained by anatomic conditions such as a short and
angulated proximal neck or narrow access vessels and an-
eurysmal extension into the iliac arteries.1-4 Comparisons
with AAA open repair revealed that EVAR has lower
morbidity and mortality rates at short-term and mid-
term follow-up intervals.5,6
Earlier endovascular technical publications reported that
patients with AAAs and associated common iliac aneurysms
(CIA) usually underwent unilateral or sometimes bilateral
internal iliac artery occlusion and therefore incurred some
reported risks, such as buttock claudication, sexual impotence,
and colonic ischemia. Symptoms of pelvic ischemia are under-
estimated, not generally predictable, and persist over many
years in most patients, despite active exercise.7-10
Morbidity andmortality rates of both open andEVARare
higher in patients with associated iliac disease than in those
with AAA only.10,11 Hobo et al12 analyzed the European
Collaborators on Stent-Graft Techniques for Aortic Aneu-
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doi:10.1016/j.jvs.2009.09.027rysm Repair (EuroSTAR) data and compared the results of
EVAR in patients with and without concomitant CIA. The
group with iliac artery disease was also composed of higher-
risk patients who also had higher rates of proximal neck and
iliac angulations, twomajor barriers to a successful proximal or
distal sealing. These patients may benefit from an endovascu-
lar approach if the distal neck is extended into the external iliac
artery and the internal iliac artery (IIA) flow is preserved using
a stent graft branch. Bifurcated devices with a side branch to
preserve the IIA circulation have been recently designed for
that purpose.10,11,13
This study describes the initial results (up to 22
months’ follow-up) of the use of iliac branched devices
(IBDs) and discusses some technical aspects and the use of
bilateral IBDs.
MATERIAL AND METHODS
From April 2006 to December 2008, 47 IBDs were
implanted in 37 patients (30 men, 7 women), of whom 10
(84% men) underwent bilateral repair of common iliac
artery aneurysms (CIAAs; Table). Their mean age was 71.2
years (range, 54-88), and they were followed up for a mean
11.6  7.5 months. The most relevant comorbidities were
smoking (63.8%), hypertension (72.3%), dyslipidemia
(46.8%), coronary disease (48.9%), and chronic obstructive
pulmonary disease (23.4%). American Society of Anesthe-
siologist classification results were class I, 12.7%; class II,
31.9%; class III, 53.1%; and class IV, 2.12%. All patients
gave informed consent. All cases were planned using min-
imum 2-mm axial slices of 64-channel computed tomogra-
phy (CT) angiography scans reconstructed by the surgical
team with the Osirix 3D software (OsiriX Foundation,
Geneva, Switzerland). Patency rates were calculated using
Kaplan-Meier survival analysis.
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eurysms 3.0 cm as the indication for IBD use, and all
received simultaneous aortic endografts (Zenith AAA En-
dovascular Graft, Cook Inc, Bloomington, Ind). Two pa-
tients received a concomitant thoracoabdominal branched
device (Cook Inc) to repair a type IV Crawford thoracoab-
dominal aortic aneurysm (Fig 1). In one case, the device
was associated with a fenestrated stent graft to treat a
juxtarenal aortic aneurysm. In patients undergoing bilateral
treatment, both iliac stent grafts were fully deployed at first,
and then the aortic stent graft’s main body delivery system,
with up to 22F, was safely introduced through the 10- or
12-mm IBD stent graft diameter.
Two IBD stent graft models were used (Fig 2 and Fig
3). The first was the helical iliac side branch (HISB), which
was implanted in the first 11 consecutive cases (23.4%).
This model has a 6- or 8-mm tubular branch emerging in a
Table. Distribution of stent graft models by aneurysm
types and treatment
Type and treatment
Total grafts
No.
HISB
No. (%)
ZBISB
No. (%)
Isolated IAA 2 0 (0) 2 (100)
Associated AAA 42 11 (26.2) 31 (73.8)
Associated juxtarenal AAA 1 0 (0) 1 (100)
Associated TAAA 2 0 (0) 2 (100)
Unilateral IBD 27 10 (21.2) 17 (36.2)
Bilateral IBD 20 1 (2.1) 19 (40.5)
AAA, Abdominal aortic aneurysm;HISB, helical iliac side branch; IAA, iliac
aortic aneurysm; IBD, iliac bifurcated device; TAAA, thoracoabdominal
aortic aneurysm; ZBISB, Zenith bifurcated iliac side branch.
Fig 1. Branched stent grafts were used to treat concomitant
common iliac artery and thoracoabdominal aortic aneurysms. The
right internal iliac artery underwent coil embolization.helical fashion from the 12-mm main body tube and hasright and left models, to be used in the right or left iliac
artery, respectively. The second was the Zenith bifurcated
iliac side branch (ZBISB), similar to the AAAZenithmodular
stent graftmain body, but smaller, to fit the iliac environment.
The sameZBISBmodel canbeused in either side.TheZBISB
device was used to treat 36 CIAAs (76.6%), and 10 of these
patients received bilateral repair, including a patient who had
both models implanted in both iliac arteries.
Both IBD models come with a preloaded indwelling
catheter and guidewire through the side branch (Fig 3).
This guidewire is snared from a contralateral or brachial
approach and guides the introduction of a sheath that will
enter the main body of the device and exit through the side
branch. At this moment, the IIA is catheterized and a
bridging covered stent is deployed, uniting the side branch
to the IIA and eliminating flow into the sac of the CIAA.
RESULTS
Technical success and perioperative complications.
The primary technical success rate in the combined series was
97.3%. The introduction of the delivery system failed in one
patient due to a heavily calcified external iliac artery, which
ruptured. This case was converted to open repair to control
bleeding, ligate the external iliac artery, and perform a femo-
rofemoral bypass. The remaining 46 IBDs were successfully
inserted. The operating time in the successful cases varied
widely (110 to220minutes) andwas inversely proportional to
Fig 2. A, Helical iliac side branch device. B, The arrows indicate
the indwelling catheter.the number of cases performed by the operating team.
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recovery. Apart from minor complications that did not
require longer hospitalization, one patient had a self-
limited lymphocele without wound infection, and another
had a minor ischemic stroke with consequent aphasia. One
patient had an external iliac artery acute occlusion in the
early postoperative period that was successfully reopened
with thrombolysis. No patients died 30 days, and up to
the time this article was prepared, two patients had died at
8 and 14 months from causes not associated with the
aneurysm.
Follow-up and patency. Five (10.6%) occlusions of
the internal iliac side branch without external iliac artery
occlusion occurred in five patients during follow-up. The
analysis of complications by IBD model revealed four oc-
clusions with the HISB and one with the ZBISB device.
Separate Kaplan-Meier curves were plotted but could not
be statistically compared because there were only 11 HISB
cases and 36 ZBISB cases, with different follow-up times.
One patient (previously mentioned) presented with exter-
nal iliac stent graft limb occlusion 16 days after surgery and
fully recovered after a repeat endovascular intervention.
This was the only case that classified as secondary patency.
Two patients with bilateral repair sustained an IIA side
branch occlusion without ischemic symptoms. The con-
Fig 3. Zenith iliac branch device.tralateral IIA seemed to supply the pelvic and coloniccollateral circulation in both patients, as seen on control CT
scans.
One man with associated AAA, right CIAA, and
chronic left IIA occlusion underwent HISB stent graft
implantation on the right side. During a hospitalization
due to gastrointestinal bleeding and severe anemia, we
found evidence that the iliac branch was occluded but
could not attempt to reopen it. He developed persistent
bilateral buttock claudication and sexual dysfunction. The
remaining two patients with occlusion were asymptomatic
at 6 and 11 months.
No endoleak, modular side branch disconnection, or
late iliac ruptures were observed. Cumulative primary pa-
tency was 85.4% and cumulative secondary patency was
87.3%, both at 22 months (standard error 10%). The
respective curves and their 95% confidence interval are
shown in Figs 4 and 5.
Technical aspects. These first 47 cases suggested
Fig 4. Primary patency up to 22 months (central line) with
standard error 10%. The peripheral lines depict the respective
95% confidence interval.
Fig 5. Secondary patency up to 22 months (central line) with
standard error 10%. The peripheral lines depict the respective
95% confidence interval.some changes in our standard procedures. When capturing
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wire are in the aortic bifurcation, it is usually difficult to
visualize and snare the wire.
Another pitfall in this procedure is the lack of stability
of the sheath during the introduction of the bridging stent,
also reported by Tielliu et al,13 when they reported the use
of a second 7F sheath inside the 12F and into the side
branch, to secure the system in place, followed by an early
retrieval of the indwelling wire. In our practice, we rou-
tinely exchange the preloaded guidewire by a 260-cm-long
Amplatz guidewire (Cook Inc). We keep the tip of the IBD
delivery system in the proximal iliac, positioning only the
Amplatz guidewire tip at the aorta. This makes it easier to
snare, because the Amplatz is stiffer and stays stable at the
aorta, facilitating its capture by the snare and, in our expe-
rience, also providing a smoother introduction of the con-
tralateral sheath (Fig 6).
Comparing our technique to the one described by
Tielliu et al, we believe that both are successful, but we do
not go as far as they do from the original technique and
only retrieve the indwelling Amplatz wire, releasing the
contralateral internal iliac branch, after the bridging stent is
in place. The bridging stent graft used in all cases has a
rather stiff deployment system and has caused the sheath to
jump out of the side branch during introduction over the
aortic bifurcation. The following procedural steps comprise
our current standard procedure:
● Migrate a 12F Ansel1 Check Flo sheath (Cook Inc)
over the through-and-through Amplatz while simulta-
neously deploying the IBD, to avoid malpositioning.
● Puncture the Check Flo valve in parallel to the Am-
platz and introduce a roadrunner guidewire and a 5F
catheter to catheterize the IIA. The Amplatz must be
maintained under tension during this step, to avoid
Fig 6. Illustration of the technical variations.A,Themain device tip
is shown inside the iliac artery while the exchanged Amplatz wire is
snared from the contralateral approach. B, The 12F sheath is in place
with the Amplatz wire still in place. This wire will be removed only
after the bridging stent is in place.C,The Fluency and theZilver stent
are both in place. The uncovered stent is implanted 1 cm forward into
the internal iliac artery, compared with the first, to avoid kinking.entangling of the parallel wires.● Measure the necessary length for the bridging stent
with a centimetered pigtail and position the bridging
stent graft. The curled tip of the pigtail is usually cut to
facilitate this measurement from the main body to the
first visible IIA branch, at least 2 cm inside the IIA.
● With the bridging stent in position, retrieve the
through-and-through Amplatz and deploy the bridg-
ing stent graft. Deploy an uncovered nitinol stent
inside the bridging stent.
None of the possible bridging stent grafts available is
resistant to kinking, and to avoid this, we have systemati-
cally deployed a self-expanding nitinol stent inside them,
creating a high-radial-force, kink-resistant system. This un-
covered stent is usually deployed 1 cm longer into the IIA.
This technique was initially described by Chuter et al14 to
avoid kinking in the visceral branches of the thoracoab-
dominal branched stent grafts, a technique we are also
familiar with. The bridging stent used in all cases was the
Fluency Stent graft (C. R. Bard Inc, Tempe, Ariz), and all
received a Zilver (Cook Inc) stent inside. This allows us to
deploy a longer bridging stent. The alternative approach to
avoid kinking would be to deploy a short bridging stent
but, on the other hand, this step could risk a future leak if
the IIA is not well sealed. Although this might increase
procedural costs, it is our view that this is the safer option
until a specific bridging stent is available for this type of
graft.
Choice between available models. During the first
cases, we only had available the HISB model. When both
models became available simultaneously, at first, there were
questions about which case would be suitable for each
model, but as the initial cases with the ZBISB were per-
formed, we found several advantages over theHISBmodel,
enough to make it our standard:
First, although the HISB has a right or left side choice,
the same ZBISB graft is applicable to both sides. Moreover,
from the eight available ZBISB sizes, we only required two
sizes to cover all 36 cases: 12 45 58 or 12 61 41.
Understanding the sizing: 12 mm of proximal diameter; 45
or 61 mm is the distance from the proximal edge to the end
of the bifurcation; 58 or 41mm is the distance from the end
of the bifurcation until the distal edge. Therefore, the most
important measure is the CIA length, to fit either the 45- or
the 61-mm graft. This makes planning simpler and requires
a smaller graft inventory in the hospital.
Second, the HISB has a longer side branch that could
partially be located along the CIA, and depending on the
aneurysm anatomy, it could be compressed, whereas the
ZBISB is shorter and will usually be entirely located inside
the aneurysm sac, without compression risk.
Third, although the patency curves were not compara-
ble, we do acknowledge that of 10 implanted HISB devices
(one was lost due to iliac rupture before deployment), four
occluded during our follow-up compared with one within
the 36 implanted ZBISB devices, and this had an effect in
our choice between models.
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flexible side branch. In our opinion, this model might
augment overlap force and can adapt better to cases in
which the side branch is not precisely deployed in front of
the IIA orifice. This is especially useful if considered the
variation of the IIA origin angle and the necessity for
awkward fluoroscopy equipment positioning to visualize it.
DISCUSSION
Common iliac artery aneurysms are associated with
AAAs in up to 20% of patients. Until recently, these patients
could not be treated by endovascular means unless the
surgeon was willing to sacrifice the IIA by coil emboliza-
tion. Devices specifically designed to treat CIAA have been
developed in recent years and are now available for the
treatment of CIAA associated with AAAs using totally
endovascular means, without the need for deliberate occlu-
sion of normal arterial branches. Therefore, this stent graft
has the potential of broadening the application of endovas-
cular technique in up to 20% of patients: all patients with
iliac aneurysms 2.5 cm referred to us in this series were
scheduled for the procedure. Ziegler et al10 recently re-
ported encouraging results with their 6-year experience
with two different generations of device. The second gen-
eration reported in this article was the same ZBISB device
used in most of our cases, and the results are as well
encouraging.
In our small series, unilateral IIA side branch occlusion
developed in two of the 10 patients treated bilaterally, but
no ischemic symptoms were observed in this subgroup. In
contrast, of the three patients with unilateral side branch
occlusion and simultaneous contralateral IIA occlusion (2
chronic and 1 coil embolization), persistent buttock clau-
dication and sexual dysfunction developed in one. We
analyzed each occlusion case closely but did not find a
plausible explanation, apart from speculations about com-
mon iliac compression of the helical branch or poor runoff.
No severe kinking was observed.
Two of 37 patients (7.4%) had a thoracoabdominal
aortic aneurysm (TAAA), and one (3.7%) had a juxtarenal
aneurysm. They were simultaneously treated with branched
or fenestrated stent grafts. The risk of paraplegia was a main
concern because long aortic stent grafts might cover signif-
icant medullary arterial circulation, and collateral blood
flow from IIA branches was preserved as an adjunct preven-
tive measure. It is known that a TAA will develop5 years
in 5% of patients with AAAs, and 20% of the TAAs are
associated with AAAs at the time of diagnosis. Therefore,
for patients whose aortic disease extends toward the tho-
racic or thoracoabdominal segment in the future, the pres-
ervation of IIA circulation may be a preventive measure
against medullar ischemia, while protecting against the
known complications of IIA occlusion.
CONCLUSIONS
The use of branched iliac stent grafts is certainly feasible
for the treatment of patients with AAA and CIAA. It
expands the possibilities of endovascular treatment becauseit is also applicable to patients with bilateral CIAA, con-
comitant TAAA, or juxtarenal aortic aneurysm.
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Dr Colin Bicknell (London, United Kingdom): Ten of your
patients had bilateral revascularization of their internal iliac arter-
ies. When you exclude both internal iliacs, the claudication rate
after a year is probably only 10%, and buttock ischemia and colonic
ischemia are a very, very rare occurrence, and these complications
do not occur with unilateral internal iliac occlusion. Given this
information, what is your justification for revascularizing both
internal iliac arteries?
Dr Marcelo Ferreira: First, I will point out that one cannot
predict the patency of any procedure, especially with those new
technologies. So if you have an occlusion in the future, we will have
the second one patent; that is my first reason to do bilateral
revascularization.
Second, if your patient in the future needs a thoracoabdominal
aneurysm repair, you are protecting his spine from ischemic com-
plications, so I think that the more blood in the pelvis, the more it
will avoid present and future ischemic complications.
As we learned when we were residents training in open sur-
gery, I can remember my chief saying that you should not close the
hypogastric arteries. More than that, we discussed about ligating
the inferior mesenteric artery based on the back pressure to decide
to reimplant or not. So now if you have the possibility to revascu-
larize both, why not?
Dr Manish Mehta (Albany, NY): Marcelo, I enjoyed the
presentation and have a question regarding the outcomes. Accord-
ing to your data, 26% of patients with branch stent grafts to the
hypogastrics went on to have limb thrombosis. What were the
outcomes in these patients? Did they go on to develop any of
the complications of hypogastric artery interruption?
Dr Ferreira:Well, we have five patients with occlusions. Two
occlusions occurred within the group with bilateral revasculariza-
tion, both are asymptomatic; in the other three cases, within the
group with unilateral revascularization, two developed symptoms,
with that qualification.
Dr Mehta: So in 60% of the patients, you didn’t need to
revascularize the hypogastrics during endovascular aneurysm re-
pair (EVAR) in that they did not develop any symptoms once the
limbs thrombosed?
Dr Ferreira: Could you predict that?
DrMehta: I am just trying to understand the data. According
to our data, of the 140 bilateral hypogastric artery interruptions
and over 250 unilateral hypogastric artery interruptions, in close to
2000 patients that underwent EVAR, we have learned that there
are procedural techniques that prevent and most certainly mini-
mize the perceived complications, including interruption on the
hypogastric artery origins only and preventing distal embolization
and preserving the iliac and femoral circumflex vessels that are
responsible for significant collateral pathways to the pelvic circula-
tion. Furthermore, in patients that develop buttock claudication,
we certainly treat the buttock claudication by placing the patients
on an exercise regimen and treating them with Pletal. With this
approach, we have noted a majority of the patients have marked
improvements in their symptoms. Do you put them on exercise
regimens, Pletal, et cetera?
Dr Ferreira: You do that some. Most patients stop exercising
to avoid symptoms. That is the reality.Dr Joseph Ricotta (Rochester, Minn): In your abstract, it said
that four of the five people with hypogastric branch occlusion did
not end up having any buttock claudication. One could conclude
from this that you did not need to branch them in the first place
because they did not develop symptoms following stent occlusion.
My question is: When do you decide you are going to branch the
hypogastric? Is it in all patients, all-comers, which is what it sounds
like you are advocating? Is it only in patients with contralateral
hypogastric occlusion? Is it in patients who require occlusion of
one hypogastric and revascularization of the other one? What is
your treatment algorithm and when do you apply this technology?
Dr Ferreira: I think it is very difficult to predict which patient
will have a small problem, a minor problem, or even a catastrophe.
You cannot predict that. So if you have the technology and you
have the knowledge to revascularize, I mean, the question from the
other side is: Why not? So you are going to occlude that artery with
a coil or revascularize?
There is an article in the Journal of Vascular Surgery in the
beginning of this year from Piergiorgio Cao in Italy, and they
compare coil embolization with branch devices. They have eight in
a total of 36 patients with endoleak with coil embolization, and just
one patient had an endoleak with a branch device.
Dr Gustavo Oderich (Rochester, Minn): I would like to
congratulate you on an excellent presentation of a large experience.
My question is in regards to the applicability of this technology to
patients who have anatomic issues in the iliac arteries, such as a
short common iliac artery, a small external or large internal iliac
artery diameter, tortuosity, and poor internal iliac artery runoff. Do
you know how many patients you are not able to offer this
technique because of anatomical issues?
Dr Ferreira: Well, this device is to treat common iliac aneu-
rysms. If you have an aneurysm in the internal iliac artery, the
patient is not a good candidate. But still, if the patient has only one
hypogastric, you can go further with your bridging stents and treat
the hypogastric aneurysm, too. We have done that one time and
have gone up to the gluteal artery. Angulation was not a problem
for us. We have done some very angulated cases, and it is only
initially difficult to go through the very small and calcified external
iliac arteries.
Dr Mark Farber (Chapel Hill, SC): I have a question about
some of the images you showed. If you look at the device
progression, you showed some helical devices, then you showed
the straight Zenith branch (Cook, Bloomington, Ind), then you
showed what you labeled your version with the flexible hypogastric
branch. But what I also saw change was the proximal length of the
device above the branch. In the first two versions, there is only one
stent. In your version, you actually have a longer proximal to dock
with the aortic component. Do you think that there is going to be
an issue with those original devices with type 3 endoleaks where it
joins, because it is sitting in a large aneurysm, and that is why you
lengthened it, and do you think that that’s something we need to
watch?
Dr Ferreira: All three models you can have with one stent or
with two stents. You decide that before the surgery. Whenever we
can, we go for the two-stent version, to have a larger overlap, but
it depends on the length of the common iliac artery.
